United Therapeutics
Price & Volume
Stats
See moreOpen | $364.18 |
Previous Close | $364.33 |
Day Range | $363.43-$370.34 |
52W Range | $208.62-$417.81 |
Market Cap | $16.2B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $2.7B |
Revenue Growth (YoY) | 22.9% |
Gross Profit (12 Mos) | $1.7B |
Diluted EPS | $22.76 |
News
See moreYahoo Finance • 4 months ago
Is Now The Time To Put United Therapeutics (NASDAQ:UTHR) On Your Watchlist?
Yahoo Finance • 4 months ago
UTHR vs. CTLT: Which Stock Should Value Investors Buy Now?
Yahoo Finance • 4 months ago
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
Yahoo Finance • 6 months ago
Investing in United Therapeutics (NASDAQ:UTHR) five years ago would have delivered you a 213% gain
About
CEO | Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. |
CFO | Mr. James C. Edgemond |
Address | 1000 Spring Street, Silver Spring, MD, United States, 20910 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,168 |
